Atopic Dermatitis (AD) Case Study

Click here for a PDF version of this case study

Outcomes

Innovaderm successfully managed this AD study
and this resulted in:

Enrollment completed 2 months earlier than planned;
Innovaderm CRU recruited 33% of patients

Study Characteristics

- Study Phase: Ib

Patient Population: 36 subjects with moderate to severe AD
IP Route of Administration: Systemic - Oral
Site distribution: 10 sites in 2 countries (USA and Canada)
Study Design: Randomized, sequential, placebo-controlled, double-blind | Multiple ascending dose (MAD): 3 sequential cohorts
Study procedures: 4.5 mm punch skin biopsies, photographs, biomarker analysis, skin microbiome, pharmacokinetics, tape stripping and efficacy-safety assessments

Study Challenges

- Recruitment during summer months; Seasonality impacts on AD flares
- Short treatment duration; 4-week treatment period
- Data and Safety Monitoring Board (DSMB) after each cohort; Challenging to manage without affecting recruitment

Key Success Factors & Strategies

Recruitment completed in 6 months vs planned 8 months

Outstanding contribution by Innovaderm's Clinical Research Unit

Recruitment Curve

Enrollment target reached 2 months ahead of schedule

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Subscribe to our newsletter

White Paper

Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”. Innovaderm is proud to have been involved in the development of such a document addressing: 1. The key success measures & best practices to ensure a well-connected end-to-end component of […]

Blog Article

3 Tips on How to Manage Rosacea Trials

In Canada, April is dedicated to raising awareness around Rosacea. One of Innovaderm’s all-star project managers, Nalanie Johnson, shared some tips that are crucial when managing a clinical trial to the complexity of a therapeutic indication such as Rosacea: 1. In managing Rosacea studies, it is important to understand the indication and patient flow. Most […]

Case Study

Hidradenitis Suppurativa (HS) Case study

Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic - Subcutaneous Site distribution: 25 in North America and 16 in Europe […]